Device type · GGP
Test, Qualitative And Quantitative Factor Deficiency
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GGP
Hematology
Device class
Class II
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
3
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Test, Qualitative And Quantitative Factor Deficiency
- Product code
- GGP
- Device class
- Class II
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7290
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for GGP
Latest FDA decisions
The 8 newest of 9 since 2015.
K251440 · Decided Aug 25, 2025 · 108 days after receipt
Device type: Test, Qualitative And Quantitative Factor Deficiency (GGP) · Laboratory Medicine & Pathology
Instrumentation Laboratory Company
K230852 · Decided Dec 13, 2023 · 260 days after receipt
Device type: Test, Qualitative And Quantitative Factor Deficiency (GGP) · Laboratory Medicine & Pathology
- vWF Ag510(k)
Siemens Healthcare Diagnostics Products GmbH
K220728 · Decided Jun 2, 2023 · 445 days after receipt
Device type: Test, Qualitative And Quantitative Factor Deficiency (GGP) · Laboratory Medicine & Pathology
6 more FDA decisions with a free account
Reports received
3
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
3
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Negative Result2
- Low Test Results1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions3
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency testOpen, Classified
Z-3047-2026 · Started Jul 29, 2026 · Posted by FDA Aug 28, 2026
Reason given: A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified
Cause as FDA categorized it: Under Investigation by firm
Z-1491-2026 · Started Feb 4, 2026 · Posted by FDA Mar 3, 2026
Reason given: The potential of out-of-range results and an underestimation of the free protein S level in normal patient plasmas. The defect only affects normal-range values.
Cause as FDA categorized it: Under Investigation by firm
Z-1227-2023 · Started Feb 1, 2023 · Posted by FDA Mar 6, 2023
Reason given: New warnings and precautionary statements on product labelling: Reagent 2 (R2) of BIOPHEN Protein C 5 contains the chemical substance - Cesium Chloride which changed classification and has become hazardous according to the CLP regulation ((EC) No 1272/2008) is suspected of damaging fertility
Cause as FDA categorized it: Other
11 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.